Author： Velamoor V.R.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.19, Iss.1, 1998-07, pp. : 73-82
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antidepressants and neuroleptic malignant syndrome
By Assion H.J. Heinemann F. Laux G.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Access to resources
Recommend
Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome
Current Pharmacogenomics, Vol. 4, Iss. 2, 2006-01 ,pp. :
Retinoic Acid Syndrome: Recognition, Prevention and Management
Drug Safety, Vol. 18, Iss. 4, 1998-04 ,pp. :
Mild neuroleptic malignant syndrome: problems of differential diagnosis
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :